The Dosimetry, Safety and Diagnostic Efficacy of ⁶⁸Ga-FC516 in Healthy Subjects and Patients With Prostate Cancer

NCT07468708 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult
Prostate Cancer

Interventions

DRUG: ⁶⁸Ga-FC516
DRUG: ⁶⁸Ga-FC516 and ⁶⁸Ga-labeled prostate cancer-targeting tracer

Sponsor

FindCure Biosciences (ZhongShan) Co., Ltd.

Collaborators

[object Object]